Clinical Trial Update: An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement

View source ↗

Summary

This clinical trial update notes an observational study evaluating infliximab in participants with Ankylosing Spondylitis involving the hip has been terminated.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Spondylitis, Ankylosing | Status: TERMINATED